1,286 articles
IEEE has amended its IP policy for Standard Essential Patents, requiring RAND licensing and setting limits on injunctions. The clarified definition of reasonable terms is expected to reduce…
The post discusses how inventors like Steve Jobs continue to receive patents even after their death through legal processes and estate actions. It analyses the implications for intellectual…
The post discusses the persistent ambiguity in the legal criteria for determining obviousness in patent matters. It assesses recent judicial trends and the impact of landmark cases like…
The new Intellectual Property Rights policy in India seeks to make patent filing more accessible to Indian innovators. The policy highlights the need for legal reforms and targeted…
The USPTO’s PTAB has invalidated True Position Inc.’s device locator patent 7,783,299 on grounds of anticipation and obviousness based on prior art. Polaris Wireless successfully challenged the patent’s…
Samsung’s reported interest in acquiring Blackberry highlights the value of Blackberry’s patent portfolio and strategic assets. The potential deal faces regulatory scrutiny in Canada and could impact competition…
Gilead’s patent for Sofosbuvir was rejected by the Indian Patent Office on grounds of insufficient therapeutic efficacy. This landmark decision enables wider access to affordable generic Hepatitis C…
The Indian Patent Office has revoked Roche’s patent on Bonviva after Cipla challenged its validity, citing a lack of inventive step and patentability. This decision highlights critical aspects…
Weekly IP Warm-UP covers notable intellectual property law updates, including copyright and patent litigation, music industry developments, and trade secrets cases. The post analyses recent legal changes and…
The Indian Patent Office set aside Abbott Biotechnology's Humira patent after Glenmark's pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges…